JP2023544853A5 - - Google Patents
Info
- Publication number
- JP2023544853A5 JP2023544853A5 JP2023521587A JP2023521587A JP2023544853A5 JP 2023544853 A5 JP2023544853 A5 JP 2023544853A5 JP 2023521587 A JP2023521587 A JP 2023521587A JP 2023521587 A JP2023521587 A JP 2023521587A JP 2023544853 A5 JP2023544853 A5 JP 2023544853A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic composition
- topical ophthalmic
- composition according
- topical
- atropine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089263P | 2020-10-08 | 2020-10-08 | |
| US63/089,263 | 2020-10-08 | ||
| US17/317,551 | 2021-05-11 | ||
| US17/317,551 US11191751B1 (en) | 2020-10-08 | 2021-05-11 | Topical ophthalmological atropine free base compositions |
| PCT/US2021/054221 WO2022076852A1 (en) | 2020-10-08 | 2021-10-08 | Topical ophthalmological compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544853A JP2023544853A (ja) | 2023-10-25 |
| JP2023544853A5 true JP2023544853A5 (https=) | 2024-10-10 |
Family
ID=78818588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521587A Pending JP2023544853A (ja) | 2020-10-08 | 2021-10-08 | 局所眼科用組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11191751B1 (https=) |
| EP (2) | EP4225284B1 (https=) |
| JP (1) | JP2023544853A (https=) |
| KR (1) | KR20230084190A (https=) |
| CN (1) | CN116390714A (https=) |
| AU (1) | AU2021359003A1 (https=) |
| BR (1) | BR112023006371A2 (https=) |
| CA (1) | CA3193940A1 (https=) |
| ES (1) | ES3063371T3 (https=) |
| MX (1) | MX2023004065A (https=) |
| WO (1) | WO2022076852A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10251875B2 (en) | 2017-05-11 | 2019-04-09 | Nevakar Inc. | Atropine pharmaceutical compositions |
| US11191751B1 (en) * | 2020-10-08 | 2021-12-07 | Ads Therapeutics Llc | Topical ophthalmological atropine free base compositions |
| MX2023009091A (es) | 2021-02-03 | 2023-08-09 | Ads Therapeutics Llc | Composiciones oftalmologicas topicas. |
| KR20240136369A (ko) * | 2022-01-21 | 2024-09-13 | 에이디에스 테라퓨틱스 엘엘씨 | 8-메틸-8-아자비사이클로[3.2.1] 옥탄-3-일의 에스테르 3-하이드록시-2-페닐프로파노에이트 |
| JP2025541009A (ja) | 2022-12-23 | 2025-12-17 | ノバリック ゲーエムベーハー | ヒヨスチアミンを含む半フッ化アルカン組成物 |
| CN117982412B (zh) * | 2024-02-04 | 2024-09-17 | 济川(上海)医学科技有限公司 | 一种醋克利定眼用组合物及其药物制剂和用途 |
| WO2025259674A1 (en) * | 2024-06-11 | 2025-12-18 | Ads Therapeutics Llc | Compositions and methods for delivery of pharmaceutical actives |
| WO2025264886A1 (en) * | 2024-06-19 | 2025-12-26 | Btv Holding, Llc | Ophthalmic preparations and methods of use |
| WO2026011139A1 (en) * | 2024-07-05 | 2026-01-08 | Ads Therapeutics Llc | Transient receptor potential melastatin 8 agonist-containing ocular conditions and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070254914A1 (en) * | 2006-05-01 | 2007-11-01 | Non-Profit Organization Chang Gung Memorial Hospital | Low-concentration atropine solution for preventing myopia progression and preparing method thereof |
| EP2335735A1 (en) * | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
| CN102526051A (zh) * | 2012-03-09 | 2012-07-04 | 哈尔滨医科大学 | 一种治疗真菌性角膜炎的眼药膏 |
| CN113679699B (zh) * | 2012-09-12 | 2022-10-28 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| US9421199B2 (en) * | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
| US11510931B2 (en) * | 2016-09-28 | 2022-11-29 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
| AU2017333420A1 (en) * | 2016-09-28 | 2019-04-04 | Novaliq Gmbh | Compositions comprising a cannabinoid receptor binding ligand |
| BR112019012568A2 (pt) * | 2016-12-22 | 2019-11-26 | Novaliq Gmbh | composições compreendendo tacrolimus para o tratamento de doenças intraoculares inflamatórias |
| WO2019068763A1 (en) * | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | OPHTHALMIC COMPOSITIONS COMPRISING F6H8 |
| TW201932104A (zh) * | 2017-11-03 | 2019-08-16 | 澳大利亞商布萊恩荷登視覺協會 | 用於控制及/或降低近視進展之醫藥組合物 |
| SG11202102820VA (en) * | 2018-10-12 | 2021-04-29 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| WO2020152046A1 (en) * | 2019-01-21 | 2020-07-30 | Novaliq Gmbh | Pharmaceutical composition for the treatment of ocular neovascularisation |
| CA3128224A1 (en) * | 2019-02-01 | 2020-08-06 | Aerie Pharmaceuticals, Inc. | Compounds, compositions and methods for treatment of myopia |
| US11191751B1 (en) * | 2020-10-08 | 2021-12-07 | Ads Therapeutics Llc | Topical ophthalmological atropine free base compositions |
| MX2023009091A (es) * | 2021-02-03 | 2023-08-09 | Ads Therapeutics Llc | Composiciones oftalmologicas topicas. |
-
2021
- 2021-05-11 US US17/317,551 patent/US11191751B1/en active Active
- 2021-10-08 CN CN202180068863.0A patent/CN116390714A/zh active Pending
- 2021-10-08 WO PCT/US2021/054221 patent/WO2022076852A1/en not_active Ceased
- 2021-10-08 ES ES21878639T patent/ES3063371T3/es active Active
- 2021-10-08 EP EP21878639.0A patent/EP4225284B1/en active Active
- 2021-10-08 MX MX2023004065A patent/MX2023004065A/es unknown
- 2021-10-08 US US18/029,323 patent/US20230355594A1/en active Pending
- 2021-10-08 EP EP25217226.7A patent/EP4706766A2/en active Pending
- 2021-10-08 KR KR1020237013835A patent/KR20230084190A/ko active Pending
- 2021-10-08 CA CA3193940A patent/CA3193940A1/en active Pending
- 2021-10-08 BR BR112023006371A patent/BR112023006371A2/pt unknown
- 2021-10-08 AU AU2021359003A patent/AU2021359003A1/en active Pending
- 2021-10-08 JP JP2023521587A patent/JP2023544853A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023544853A5 (https=) | ||
| US12485177B2 (en) | Topical ophthalmological compositions | |
| CN116390714A (zh) | 局部眼科组合物 | |
| KR102017916B1 (ko) | 노안, 경도 원시 및 불규칙한 난시의 치료를 위한 조성물 및 방법 | |
| EP2506843A2 (en) | Treating xerophthalmia with compounds increasing meibomian gland secretion | |
| US20200345633A1 (en) | Pharmaceutical Compositions for Controlling and/or Reducing the Progression of Myopia | |
| JP2013534527A (ja) | コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物 | |
| JP2021501803A5 (https=) | ||
| KR20220018484A (ko) | 시력 장애를 치료하기 위한 방법 및 제형 | |
| WO2025034554A1 (en) | Compositions and methods for delivery of ophthalmological actives | |
| US9187468B2 (en) | Topical ocular analgesic agents | |
| TWI816660B (zh) | 噻托銨用於製造預防近視、治療近視及/或預防近視增長之點眼劑之用途 | |
| US20260124305A1 (en) | Topical ophthalmological compositions | |
| US4764530A (en) | Pharmaceutical compositions and their use as mydriatics | |
| WO2022103250A1 (es) | Composición oftalmológica sinérgica en dosis de baja concentración eficaz en la prevención, control y erradicación de la presbicia | |
| HK40086649A (zh) | 局部眼科组合物 | |
| CN120093684A (zh) | 局部眼科组合物 | |
| WO2026036096A1 (en) | Compositions and methods for ocular application | |
| HK40119760A (zh) | 用於治疗眼病的组合物及方法 |